Erhan Hocaoğlu, E. Aydemir, C. Ateş, Filiz MERCAN SARIDAŞ, O. F. Nas, M. F. Inecikli, S. Cander, Özen Öz Gül, E. Ertürk, C. Ersoy
{"title":"射频消融治疗复发性甲状腺乳头状癌患者的单中心回顾性分析","authors":"Erhan Hocaoğlu, E. Aydemir, C. Ateş, Filiz MERCAN SARIDAŞ, O. F. Nas, M. F. Inecikli, S. Cander, Özen Öz Gül, E. Ertürk, C. Ersoy","doi":"10.46310/tjim.1073526","DOIUrl":null,"url":null,"abstract":"Background Radiofrequency ablation (RFA) is used in selected patients with recurrent or metastatic thyroid cancer who have high surgical risk or do not accept surgical treatment. However, long-term follow-up data are limited. Here, we present our single-center experience with the use of RFA in the treatment of recurrent or metastatic papillary thyroid carcinoma (PTC). Material and Methods Patients","PeriodicalId":23372,"journal":{"name":"Turkish Journal of Internal Medicine","volume":"62 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A Single Center Retrospective Analysis of Patients with Recurrent Papillary Thyroid Carcinoma Undergoing Radiofrequency Ablation\",\"authors\":\"Erhan Hocaoğlu, E. Aydemir, C. Ateş, Filiz MERCAN SARIDAŞ, O. F. Nas, M. F. Inecikli, S. Cander, Özen Öz Gül, E. Ertürk, C. Ersoy\",\"doi\":\"10.46310/tjim.1073526\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background Radiofrequency ablation (RFA) is used in selected patients with recurrent or metastatic thyroid cancer who have high surgical risk or do not accept surgical treatment. However, long-term follow-up data are limited. Here, we present our single-center experience with the use of RFA in the treatment of recurrent or metastatic papillary thyroid carcinoma (PTC). Material and Methods Patients\",\"PeriodicalId\":23372,\"journal\":{\"name\":\"Turkish Journal of Internal Medicine\",\"volume\":\"62 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-03-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Turkish Journal of Internal Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.46310/tjim.1073526\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Turkish Journal of Internal Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.46310/tjim.1073526","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
A Single Center Retrospective Analysis of Patients with Recurrent Papillary Thyroid Carcinoma Undergoing Radiofrequency Ablation
Background Radiofrequency ablation (RFA) is used in selected patients with recurrent or metastatic thyroid cancer who have high surgical risk or do not accept surgical treatment. However, long-term follow-up data are limited. Here, we present our single-center experience with the use of RFA in the treatment of recurrent or metastatic papillary thyroid carcinoma (PTC). Material and Methods Patients
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
